84
https://pubmed.ncbi.nlm.nih.gov/38091486
The study suggests that 1,5-anhydroglucitol could serve as a potential biomarker for assessing adherence to Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in people with diabetes.